Common Stock

Represents shares of common stock, par value $0.0001 per share ("Common Stock") withheld in an exempt disposition to the Issuer under Rule 16b-3(e) to satisfy tax withholding obligations of the reporting person arising out of the vesting of previously reported restricted stock units ("RSUs").

Includes 14,492 shares of Common Stock underlying RSUs granted to the reporting person on August 11, 2023 (the "August 2023 Grant Date"), 71,274 shares of Common Stock underlying RSUs granted to the reporting person on September 16, 2024 (the "September 2024 Grant Date"), and 77,124 shares of Common Stock underlying RSU's granted to the reporting person on August 1, 2025 (the "August 2025 Grant Date") in each case, pursuant to the Issuer's 2023 Incentive Plan. One-Third (1/3) of the RSUs initially granted to the reporting person on August 11, 2023 vested and were delivered to the reporting person on August 11, 2024, the first anniversary of the August 2023 Grant Date, and one-third of the RSUs subject to the grant shall vest and be deliverable to the reporting person on each of the second and third anniversaries of the August 2023 Grant Date, subject to continued service through each such vesting date.

(Continuation of the Footnote (2)) One-Third (1/3) of the RSUs granted to the reporting person on September 16, 2024 shall vest, and an equal number of shares of Common Stock will be deliverable to the reporting person, on each of the first three anniversaries of the September 2024 Grant Date, subject to continued service through each such vesting date. One-Third (1/3) of the RSUs granted to the reporting person on August 1, 2025 shall vest, and an equal number of shares of Common Stock will be deliverable to the reporting person, on each of the first three anniversaries of the August 2025 Grant Date, subject to continued service through each such vesting date.

Represents a buy and hold exercise by the reporting person of a stock option that was set to expire on February 24, 2031.

The stock options were immediately exercisable, subject to a right of repurchase in favor of the Issuer, which lapses as the stock option vests. The options were fully vested as of 12/31/2024.

/s/ Bill Roeschlein, as attorney-in-fact


Includes 57,971 shares of Common Stock underlying RSUs granted to the reporting person on August 11, 2023 (the "August 2023 Grant Date"), 333,330 shares of Common Stock underlying RSUs granted to the reporting person on September 16, 2024 (the "September 2024 Grant Date"), and 360,687 shares of Common Stock underlying RSU's granted to the reporting person on August 1, 2025 (the "August 2025 Grant Date") in each case, pursuant to the Issuer's 2023 Incentive Plan. One-Third (1/3) of the RSUs initially granted to the reporting person on August 11, 2023 vested and were delivered to the reporting person on August 11, 2024, the first anniversary of the August 2023 Grant Date, and one-third of the RSUs subject to the grant shall vest and be deliverable to the reporting person on each of the second and third anniversaries of the August 2023 Grant Date, subject to continued service through each such vesting date.


Includes 25,362 shares of Common Stock underlying RSUs granted to the reporting person on August 11, 2023 (the "August 2023 Grant Date"), 177,776 shares of Common Stock underlying RSUs granted to the reporting person on September 16, 2024 (the "September 2024 Grant Date"), and 192,366 shares of Common Stock underlying RSU's granted to the reporting person on August 1, 2025 (the "August 2025 Grant Date") in each case, pursuant to the Issuer's 2023 Incentive Plan. One-Third (1/3) of the RSUs initially granted to the reporting person on August 11, 2023 vested and were delivered to the reporting person on August 11, 2024, the first anniversary of the August 2023 Grant Date, and one-third of the RSUs subject to the grant shall vest and be deliverable to the reporting person on each of the second and third anniversaries of the August 2023 Grant Date, subject to continued service through each such vesting date.


Includes 14,493 shares of Common Stock underlying RSUs granted to the reporting person on August 11, 2023 (the "August 2023 Grant Date"), 71,396 shares of Common Stock underlying RSUs granted to the reporting person on September 16, 2024 (the "September 2024 Grant Date"), and 77,255 shares of Common Stock underlying RSU's granted to the reporting person on August 1, 2025 (the "August 2025 Grant Date") in each case, pursuant to the Issuer's 2023 Incentive Plan. One-Third (1/3) of the RSUs initially granted to the reporting person on August 11, 2023 vested and were delivered to the reporting person on August 11, 2024, the first anniversary of the August 2023 Grant Date, and one-third of the RSUs subject to the grant shall vest and be deliverable to the reporting person on each of the second and third anniversaries of the August 2023 Grant Date, subject to continued service through each such vesting date.


These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 1/3 of the shares shall vest one year from the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter on the 15th of November, February, May and August, subject to the Reporting Person continuing to be an employee through each such date, or as provided under the Issuer's 2015 Equity Incentive Plan.


Pursuant to the approved sell-to-cover plan by the Compensation Committee for all executive officers, shares were sold solely to cover the associated tax liability upon the vesting of a previously granted award of Restricted Stock Units (RSUs).

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.64 to $3.65, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Includes 220,073 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met with respect to certain performance stock units ("PSUs") granted to the Reporting Person on August 21, 2024.

Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of RSUs and PSUs.


Sitio Royalties Operating Partnership, LP Units

Class A Common Stock

In connection with merger of the Issuer with Viper Energy, Inc., the reporting person disposed of all issuer equity securities in exchange for the merger consideration pursuant to the Agreement and Plan of Merger dated as of June 2, 2025, by and among the parties thereto.

The reported securities were directly held by (i) Source Energy Permian II, LLC ("Source"), as the direct holder of securities, (ii) Sierra Energy Royalties, LLC ("Sierra") (iii) Source Energy Partners, LLC ("Source Energy") (iv) OCM FIE, LLC ("FIE"). Oaktree Capital Management L.P., Oaktree Capital Holdings, LLC and Oaktree Capital Group Holdings GP LLP are the indirect managers of Source, Sierra, Source Energy, and FIE, but each of the foregoing disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein.

Each Sitio Royalties Operating Partnership, LP Unit, together with a share of Class C Common Stock, is exchangeable, for no additional consideration, into one share of Class A Common Stock.

/s/ See Signatures Included in Exhibit 99.1


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.63 to $3.65, inclusive. The reporting person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Includes 273,069 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, following vesting, one share of the Issuer's Common Stock. 100% of the shares shall vest on the one-year anniversary of the grant date, subject to the Reporting Person continuing to be an employee through such date, or as provided under the Issuer's 2015 Equity Incentive Plan.


Includes 2,061,863 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


Ahmadian Radin

C/O COLLER PRIV MKT SECONDARIES ADVISORS

Purchase as of 8/1/2025 for which NAV pricing was finalized on 8/20/2025.


Includes 201,700 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


Includes 280,615 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units.

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.87 to $16.73, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on  December 12, 2024, by the Reporting Person, with a plan end date of February 27, 2026.

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.43 to $15.65, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Reporting Person's Title: Executive Vice President and Chief Medical Officer

/s/ Latha Vairavan, Attorney-in-Fact for Patrick Burnett


Pursuant to the approved sell-to-cover plan by the Compensation Committee for all executive officers, shares were sold solely to cover the associated tax liability upon the vesting of a previously granted award of Restricted Stock Units (RSUs).

Includes 560,275 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


Includes 282,238 RSUs which are payable in an equivalent number of shares of the Issuer's common stock.


Common Stock, par value $0.001 per share

The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin Capital"), the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of the Master Fund, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP.

Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.


Non-Qualified Stock Option (right to buy)

Common Stock

Option will vest based on achievement of certain performance criteria relating to earnings growth.


Common Stock

Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.

This transaction was executed in multiple trades at prices ranging from $26.19 to $27.15 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.

On June 8, 2025, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). All amounts of securities listed herein have been adjusted to reflect the effect of the Reverse Stock Split.

These stock options were granted on December 13, 2023 under the 2017 Plan and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a monthly pro-rata basis over a period of three years from the date of grant.

The Organization and Compensation Committee of the Board of Directors of the Issuer determined on July 17, 2025 that the performance-based vesting requirement for these stock options was satisfied and these stock options vested on August 19, 2025 (subject to remaining time-based vesting requirements).


Common Stock

This number includes 508 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).


Common Stock


Seros Alexandra

C/O ENTRAVISION COMMUNICATIONS CORPORATI

By Non-Exempt Marital Trust under Seros Ulloa Family Trust of 1996

By Bypass Trust under Seros Ulloa Family Trust of 1996(5

By Survivor's Trust under Seros Ulloa Family Trust of 1996(3

By Survivor's Trust under the Seros Ulloa Family Trust of 1996

By Walter F. Ulloa Irrevocable Trust of 1996

On September 9, 2024, the Estate of Walter F. Ulloa (the "Estate") was settled into sub-trusts under the Seros Ulloa Family Trust of 1996 (the "Family Trust") as follows: 1,220,201 shares of Class A Common Stock were settled into the Survivor's Trust under the  Family Trust; 1,087,571 shares of Class A Common Stock were settled into the Non-Exempt Marital Trust under the Family Trust; and 344,840 shares of Class A Common Stock were settled into the Bypass Trust under the Family Trust.

On February 10, 2023, 150,000 shares of Class A Common Stock held by the Estate were exercised pursuant to a stock option, with 99,829 shares of Class A Common Stock delivered to the Estate and 50,171 shares of Class A Common Stock withheld to satisfy stock option exercise costs and tax withholding obligations, in transactions by the executor of the Estate, exempt from Section 16 of the Securities Exchange Act of 1934 under Rule 16a-2(d).

These securities are owned directly by the Survivor's Trust under the Family Trust, and indirectly by Alexandra Seros as the trustee of such trust.  Ms. Seros disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.

These securities are owned directly by the Non-Exempt Marital Trust under the Family Trust, and indirectly by Alexandra Seros as the trustee of such trust.  Ms. Seros disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.

These securities are owned directly by the Bypass Trust under the Family Trust, and indirectly by Alexandra Seros as the trustee of such trust.  Ms. Seros disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.

Since the Reporting Person's last report, 425 shares were transferred from direct ownership to indirect ownership through the Family Trust for no consideration.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.37 to $2.43, inclusive. The Reporting Person undertakes to provide to Entravision Communications Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.33 to $2.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

These securities are owned directly by the Ulloa Irrevocable Trust and indirectly by Thomas Strickler as the sole trustee of such trust.  Alexandra Seros disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, if any.

Exhibit 24.1 - Power of Attorney by Alexandra Seros; Exhibit 24.2 - Power of Attorney by The Seros Ulloa Family Trust


Class A Common Stock

Class A Common Stock

The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis. The Class B Common Stock will automatically convert into shares of the Issuer's Class A Common Stock on a one-to-one basis upon the earlier of (a) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions, (b) the date and time, or the occurrence of an event, specified by vote or written consent of the holders of at least 80% of the outstanding shares of Class B common stock at the time of such vote or consent, voting as a separate series or (c) the 20-year anniversary of the closing of the Issuer's initial public offering.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024.


The price reported in this Column 4 is a weighted average price. These shares were purchased in multiple transaction prices ranging from $2.05 to $2.16, inclusive. The reporting person undertakes to provide to Prairie Operating Co. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in footnote (1) to this Form 4.


Common Stock

The option vests over a four year period, with 25% of the total number of shares subject to the option vesting on the August 11, 2026, and the balance vesting in 12 equal quarterly installments thereafter.


Class B Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on September 11, 2024.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $338.49 to $339.44, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $339.49 to $340.46, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $340.50 to $341.37, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $341.59 to $342.42, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $343.19 to $344.16, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $344.68 to $345.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $345.85 to $346.53, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $347.07 to $347.91, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from 348.22 to $349.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $351.04 to $351.48, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $352.20 to $352.60, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $353.61 to $354.52, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $354.66 to $355.42, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $358.83 to $359.77, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

The shares subject to the option are fully vested and exercisable.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock in connection with: (i) any transfer, whether or not for value, except for certain permitted transfers further described in the Issuer's amended and restated certificate of incorporation, (ii) such time as the aggregate number of shares of Class B Common Stock outstanding ceases to represent 5% of the aggregate number of shares of Common Stock outstanding, and (iii) the death of the Reporting Person.

Shares held by SBH Trust dated March 10, 2020, of which Reporting Person is Trustee.

/s/ Stephen Chen, as Attorney-in-Fact for Severin Hacker


Represents (i) 49,188 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 8, 2023; (ii) 3,514 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 8, 2024; and (iii) 6,833 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 24, 2025.

/s/ Yijun Han, as Attorney-in-Fact for Ossa Fisher


Represents (i) 1,351 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 15, 2022; (ii) 27,251 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on June 14, 2023; (iii) 7,787 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 8, 2024; and (iv) 15,141 shares of Class A common stock withheld by the Issuer to cover the reporting person's tax withholding obligation upon the quarterly vesting of Restricted Stock Units granted on March 24, 2025.

/s/ Yijun Han, Attorney-in-fact for David Maday


The common stock was purchased directly from the Company in a private placement transaction.

CMED Partners LLLP: /s/ Vern D. Kornelsen, General Partner


The Reporting Person purchased 1,000,000 shares at a price of $0.10 cents per share as part of the private placement contemplated by that Securities Purchase Agreement dated 8/19/2025.


These shares sold pursuant to a 10b5-1 plan dated November 21, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $65.81 to $66.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19.

The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $66.81 to $66.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $64.585 to $65.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Benjamin C. Singer, Attorney-in-Fact


The Reporting Person purchased 750,000 shares at a price of $0.10 cents per share as part of the private placement contemplated by that Securities Purchase Agreement dated 8/19/2025.


The reported securities were repurchased by the Issuer.

The reported securities are directly held by Oaktree Value Opportunities Fund Holdings, L.P., OCM Opps GTM Holdings LLC, Oaktree Phoenix Investment Fund, L.P.  and Oaktree Opportunities Fund Xb Holdings (Delaware), L.P. (collectively, the "Direct Holders"), which securities may be deemed beneficially owned by the direct and indirect managers or general partners of the Direct Holders including Oaktree Capital Holdings, LLC and Oaktree Capital Group Holdings GP, LLC.

Each Reporting Person expressly disclaims beneficial ownership of the reported securities except of such Reporting Person's pecuniary interest therein.


The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted September 5, 2024.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.63 to $14.28 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.48 to $13.81 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The shares are held of record by Dustin A. Moskovitz TTEE Dustin A. Moskovitz Trust DTD 12/27/05.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.86 to $44.92, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1 to this Form 4.


Common Stock

Each restricted stock unit represents a conditional right to receive one share of the Company's common stock.

The restricted stock units vest on January 8, 2026. Delivery of the shares to the reporting person will occur on January 8, 2026, subject to the reporting person's continued service with the Company.


Chad J. Wiener, as Attorney-in-fact for Christopher S. Lynch


The price reported $84.97 is the weighted average price.  The shares were sold in multiple transactions at prices ranging from $84.90  to $85.02 per share, both inclusive.  The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Includes 15,296 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,948 shares on November 20, 2025. 1,964 shares on March 6, 2026, 1,324 shares on each of May 20, 2026, August 20, 2026, and November 20, 2026, 1,332 shares on March 6, 2027, 1,012 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 1,016 shares on March 6, 2028, 506 shares of each on May 20, 2028, August 20, 2028, and November 20, 2028, and 510 shares on March 6, 2029, if he is an employee of the Company on those dates.


The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

This figure is the weighted average sales price of multiple trades ranging from $5.90 to $6.32 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.


The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.96 to $32.55. The Reporting Person undertakes to provide to Resideo Technologies, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4.

These securities are owned directly by CD&R Channel Holdings II, L.P. ("CD&R Holdings II"). CD&R Investment Associates XII, Ltd. ("CD&R Holdings GP") is the general partner of CD&R Holdings II and may be deemed to beneficially own the reported securities. Investment and voting decisions with respect to the reported securities are made by majority vote of an investment committee (the "Investment Committee") of limited partners of CD&R Associates XII, L.P. ("CD&R Associates"), which may be deemed to beneficially own the reported securities. Each of CD&R Holdings GP and CD&R Associates, as well as each member of the Investment Committee, expressly disclaims beneficial ownership of the reported securities, except to the extent of their respective pecuniary interest therein.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.52 to $32.36.

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $31.59 to $32.40.


Represents shares of common stock sold to cover income tax liabilities in connection with the vesting of restricted stock unit awards pursuant to sell-to-cover arrangements implemented by the Issuer, which the Reporting Person may elect to pay in cash, and does not represent discretionary transactions by the Reporting Person.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $ 7.3901 to $ 7.455, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Includes shares represented by RSUs, of which 7,178 settled on August 20, 2025 and were then reduced by the 2,512 shares sold for taxes as reported on this Form 4.

/s/ Stephen Sonne, attorney-in-fact on behalf of Trevor Thatcher


Includes shares represented by RSUs, of which 8,995 settled on August 20, 2025 and were then reduced by the 3,236 shares sold for taxes as reported on this Form 4.


By: Isabelle Bertin-Bailly, Attorney-in-Fact For: Yvonne Wassenaar


Includes shares represented by RSUs, of which 14,991 settled on August 20 2025 and were then reduced by the 6,406 shares sold for taxes as reported on this Form 4.

/s/ Stephen Sonne, attorney-in-fact on behalf of Kristi Martindale


Includes shares represented by RSUs, of which 34,600 settled on August 20, 2025 and were then reduced by the 14,809 shares sold for taxes as reported on this Form 4.

/s/ Stephen Sonne, attorney-in-fact on behalf of Denis Garagic


The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the settlement and release of performance stock units. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary transactions by the Reporting Person

Price reported is a weighted-average sales price. The shares were sold at prices ranging from $0.5632 to $0.5665. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Shares include  9,375 shares earned upon the satisfaction of the performance condition of certain performance stock units granted to the Reporting Person on November 10, 2021, for which the Company's Board of Directors determined that the performance milestone was met on December 22, 2022 and the performance stock units were fully vested, but were not to be released to the Reporting Person until settlement. The performance stock units were settled and released on August 19, 2025.


These shares were purchased in two separate transactions at prices of $12.35 and $12.57 per share. The Reporting Person undertakes to provide, upon request, to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased at each price set forth in this footnote.

Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 118 RSUs that are scheduled to vest on September 13, 2025; and (ii) 1,359 RSUs that are scheduled to vest on November 29, 2025.

/s/ Audrey Lee, by power of atty., for Harry Sloan


The reporting person has voting and dispositive power over the securities held by Fusfield Family Irrevocable Trust ("Fusfield Trust"), and therefore may be deemed to indirectly beneficially own the securities held by Fusfield Trust. The reporting person disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

/s/ Inga Fyodorova, as Attorney-in-Fact for Glenn Fusfield


The reported price is a volume weighted average price ("VWAP"). The reported securities were sold in open market transactions at prices ranging from $21.85 to $21.89, inclusive. The reporting person undertakes to provide to the SEC, the Issuer or any stockholder of the Issuer, upon request, the number of shares sold at each price within such range.

The reported price is a VWAP. The reported securities were sold in open market transactions at prices ranging from $21.80 to $21.90, inclusive. The reporting person undertakes to provide to the SEC, the Issuer or any stockholder of the Issuer, upon request, the number of shares sold at each price within such range.

The reported price is a VWAP. The reported securities were sold in open market transactions at prices ranging from $21.55 to $21.67, inclusive. The reporting person undertakes to provide to the SEC, the Issuer or any stockholder of the Issuer, upon request, the number of shares sold at each price within such range.

After giving effect to all the transactions reported on this Statement, the reported securities are owned as follows: (i) 251,903 Common Shares are held by Heyer Investment Management, LLC (ii) 31,219 Common Shares are held by Harris Reid Heyer Trust, (iii) 27,219 Common Shares are held by James Heyer Trust, (iv) 8,000 Common Shares are held by Peter Justin Heyer Trust and (v) 25,000 Common Shares are held by William Heyer Trust. The reporting person is (i) a trustee of each of Harris Reid Heyer Trust, James Heyer Trust, Peter Justin Heyer Trust, and William Heyer Trust, and (ii) the managing member of Heyer Investment Management, LLC, and, accordingly may be deemed to beneficially own the securities held by the foregoing, but disclaims such beneficial ownership, except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

The reported securities are held and independently managed by Mindy Heyer, the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities.

/s/ Inga Fyodorova, as Attorney-in-Fact for Andrew Heyer


The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commissions, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1).


This Form 4 is filed to amend the reporting person's prior Form 4 filing on July 31, 2025 to correct the transaction date of the sale reported in Table 1 as June 30, 2025 to July 30, 2025.

/s/ Valentina Margulis, as Attorney-in-Fact for Frances H. Arnold


/s/ Deborah Berenjfoorosh, Attorney-in-Fact For: Luis A Ubinas


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 28, 2025.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.16 to $33.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

The number of shares held reflects the transfer of 4,578 shares of Class A Common Stock from AE and NS, Co-Trustees of the ES Trust, over which the Reporting Person has voting or investment power (the "ES Trust"), to the Reporting Person.

Consists of shares held by the ES Trust.

Executive Vice President, Chief Legal Officer and Secretary


The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by SB and HB, Co-Trustees of the Biswas Family Trust u/a/d 7/13/2012, over which the Reporting Person has voting or investment power (the "Biswas Family Trust").

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.025 to $34.02, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Consists of shares held by the Biswas Family Trust.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.03 to $34.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by Jordan Park Trust Company LLC, Trustee, by Courtney J. Maloney as Trust Officer.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.60 to $34.065, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Consists of shares held by Jordan Park Trust Company, LLC, Trustee of The Biswas Trust I u/a/d 11/11/2021, over which the Reporting Person has voting or investment power.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.04 to $34.03, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Consists of shares held by Jordan Park Trust Company, LLC, Trustee of The Biswas Trust II u/a/d 10/14/2021, over which the Reporting Person has voting or investment power.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.04 to $34.11, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.07 to $32.91, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.235 to $32.815, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

/s/ Adam Eltoukhy, attorney-in-fact on behalf of Sanjit Biswas


The sales were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by John C. Bicket, Trustee of the John C. Bicket Revocable Trust u/a/d 2/15/2013, over which the Reporting Person has voting or investment power (the "Bicket Revocable Trust").

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.03 to $34.02, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Consists of shares held by the Bicket Revocable Trust.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $34.03 to $34.11, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.60 to $34.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Consists of shares held by Jordan Park Trust Company, LLC, Trustee of The Bicket-Dobson Trust I u/a/d 11/10/2021, over which the Reporting Person has voting or investment power.

Consists of shares held by Jordan Park Trust Company, LLC, Trustee of The Bicket-Dobson Trust II u/a/d 10/8/2021, over which the Reporting Person has voting or investment power.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.06 to $33.055, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $33.06 to $33.10, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $32.24 to $32.815, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Executive Vice President, Chief Technology Officer

/s/ Adam Eltoukhy, attorney-in-fact on behalf of John Bicket


Class A Common Stock

Shares of Class V-1 Common Stock of the Issuer have no economic rights and each share of Class V-1 Common Stock entitles its holder to 1 vote per share.

The term "Symbotic Holdings Units" is used herein to represent limited liability company units of Symbotic Holdings LLC ("Symbotic Holdings") and an equal number of paired shares of Class V-1 Common Stock of the Issuer, which, pursuant to the limited liability company agreement of Symbotic Holdings, are redeemable by the holder on a one-for-one basis for a share of Class A Common Stock of the Issuer, subject to conversion rate adjustments for stock splits, stock dividends, reclassification and other similar transactions, and in accordance with other terms and conditions set forth in Symbotic Holdings' Second Amended and Restated Limited Liability Company Agreement, dated as of June 7, 2022. Upon redemption, the Issuer will cancel the Symbotic Holdings Units and cancel and retire for no consideration the redeemed shares of Class V-1 Common Stock.

On August 19, 2025, the Reporting Person sold an aggregate of 25,000 shares of Class A Common Stock (the "Stock Sale").  In connection with the Stock Sale, effective August 19, 2025, the Reporting Person redeemed 25,000 Symbotic Holdings Units in exchange for an equal number of shares of Class A Common Stock (the "Redemption"). In connection with the Redemption, Symbotic Holdings cancelled the Symbotic Holdings Units and the Issuer cancelled and retired for no consideration the redeemed 25,000 shares of Class V-1 Common Stock.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $46.38 to $47.36, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $47.415 to $48.41, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $48.42 to $49.37, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

In accordance with SEC guidance authorizing aggregate reporting of same-day purchases and sales, the shares were sold in multiple transactions at prices ranging from $49.63 to $49.99, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

/s/ Corey Dufresne, Attorney-in-Fact for Charles Kane


Non-qualified Stock Option (Right to Buy)

Common Stock

As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 9, 2025.

Shares held in the reporting person's name or in the Marc R. Benioff Revocable Trust.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $244.9120 to $245.8999 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $245.9231 to $246.8906 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Weighted average price.  These shares were sold in multiple transactions at prices ranging from $246.9174 to $247.3052 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Shares held in the Marc Benioff Fund LLC (the "Fund").  Fund interests are held in the reporting person's name or in trust.

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

/s/ Andrew Leeds, Attorney-in-Fact for Marc Benioff


The original Form 4, filed August 20, 2025, did not reflect the stock sale on August 20, 2025.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.

This transaction was executed in multiple trades at prices ranging from $20.00 to $20.03. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.57 to $198.57, inclusive. The Reporting Person undertakes to provide to any security holder of Alphabet Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) to (4) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.57 to $199.57, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.57 to $200.57, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.57 to $201.57, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.77 to $202.77, inclusive.

Class C GSUs entitle the Reporting Person to receive one share of Alphabet Inc. Class C capital stock for each share underlying the GSU as GSU vests. 1/12th of the GSU vested on March 25, 2023 and an additional 1/12th of the GSU vests quarterly thereafter until the GSUs are fully vested, subject to continuing employment on the applicable vesting dates.

All transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on December 2, 2024.

s/ Valentina Margulis, as Attorney-in-Fact for Sundar Pichai


This transaction was executed in multiple trades at prices ranging from $19.0925 to $20.08. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The shares are held by The Lyssikatos Revocable Trust 12/15/2011 for which the Reporting Person serves as trustee.

This transaction was executed in multiple trades at prices ranging from $20.00 to $20.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.


KRATOS DEFENSE & SECURITY SOLUTIONS, INC.

This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 20, 2025.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $63.74 to $64.72 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $64.75 to $65.73 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $65.80 to $66.36 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $67.04 to $67.96 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Includes 16,626 shares purchased through Issuer's Employee Stock Purchase Plan and approximately 19,746 shares held through Issuer's 401(k) Plan.

Deanna H. Lund, by Eva Yee, Attorney-In-Fact


Includes 27,179 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable.


Represents 14,238 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. The RSUs will vest and be settled in six equal semi-annual installments over a three year period, subject to the Reporting Person's continuation of service with the Company. These RSUs have been granted under the Company's 2025 Long Term Incentive Program as non-cash stock awards. Each RSU shall entitle its holder to receive one Common Stock of the issuer.

Represents the number of shares withheld and returned to the plan to cover the tax liability of the August 19, 2025 vesting of a previously reported restricted share grant represented in Table I.

Includes 22,475 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable.


Represents 46,824 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable. The RSUs will vest and be settled in six equal semi-annual installments over a three year period, subject to the Reporting Person's continuation of service with the Company. These RSUs have been granted under the Company's 2025 Long Term Incentive Program as non-cash stock awards. Each RSU shall entitle its holder to receive one Common Stock of the issuer.

Includes 76,057 shares underlying restricted stock units ("RSUs") that are not yet vested and deliverable.


By the AMKE Trust dated February 1, 2019

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Represents the conversion of Class B Common Stock into Class A Common Stock held of record by the Reporting Person.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.94 to $102.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.94 to $103.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.94 to $104.68. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.68 to $102.67. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.68 to $103.67. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.68 to $104.46. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth in this footnote.

The Class B Common Stock is convertible into an equal number of shares of Class A Common Stock at any time, at the holder's election. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock upon any transfer, whether or not for value, except for certain permitted transfers, or upon the occurrence of certain specified events, in each case as set forth in the Issuer's Amended and Restated Certificate of Incorporation.


The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $32.77 to $33.06, inclusive. The reporting person undertakes to provide to Hilltop Holdings Inc., any stockholder of Hilltop Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $32.82 to $33.01, inclusive. The reporting person undertakes to provide to Hilltop Holdings Inc., any stockholder of Hilltop Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $32.97 to $33.28, inclusive. The reporting person undertakes to provide to Hilltop Holdings Inc., any stockholder of Hilltop Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.


These shares of the Issuer's common stock were purchased in multiple transactions at prices ranging from $13.165 to $13.19, inclusive. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

Purchased by RSG Holdings Inc., which is wholly owned by the reporting person.

Held by RSG (US Holdings) Limited Partnership, which is controlled by the Reporting Person.

/s/ Stephen Preston as Attorney-in-Fact for Robert Green


Shares were acquired through dividend reinvestment on August 15, 2025.

/s/ Shannon R. Livingston, Attorney-in-Fact for James W. Lokey


Common Stock

The dividend equivalent rights were converted into, and paid in the form of, shares of the Issuer's common stock on a one-for-one basis in connection with the vesting of restricted stock units to which the dividend equivalent rights relate.  A cash amount was also paid to the holder to settle a fractional dividend equivalent right.

Payment of tax obligation by withholding securities incident to the vesting of securities in accordance with Rule 16b-3(e).

By: /s/ Sandra Garcia Attorney-in-Fact For: Gene Zamiska


Common Stock

By: /s/ Sandra Garcia Attorney-in-Fact For: Cynthia Tregillis


Common Stock

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.

By: /s/ Sandra Garcia Attorney-in-Fact For: Irving Tan


Common Stock

By: /s/ Sandra Garcia Attorney-in-Fact For: Vidyadhara K. Gubbi


Common Stock

By: /s/ Sandra Garcia Attorney-in-Fact For: Brian Scott Davis


Reflects the weighted average price of 750 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $27.18 to $27.1899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

/s/ Michael Shapiro, attorney-in-fact for Mr. Pate


The securities are directly held by certain private investment funds and/or certain accounts (the "Applicable Accounts") managed by Eagle Point Credit Management LLC ("EPCM"). Eagle Point DIF GP I LLC ("DIF GP") serves as general partner to certain Applicable Accounts.

EPCM and DIF GP could be deemed to have an "indirect pecuniary interest" (within the meaning of Rule 16a-1(a)(2)(ii) under the Securities Exchange Act of 1934) in securities reported herein.

Each of the Reporting Persons hereby disclaims beneficial ownership of the securities described in this report pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934 and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of any of the reported securities for purposes of Section 16 or for any other purpose.

The price reported reflects the weighted average price per share. These securities were sold in multiple transactions at prices ranging from $22.30 to $22.33 per share, inclusive. Upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Reflects the weighted average price of 36,000 shares of common stock of Option Care Health, Inc. purchased by the reporting person in multiple transactions on August 20, 2025 with purchase prices ranging from $26.92 to $27.20 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

/s/ Michael Shapiro, attorney-in-fact for Mr. Kraemer


/s/ Michael Shapiro, attorney-in-fact for Mr. Sullivan


/s/ Michael Shapiro, attorney-in-fact for Mr. Golding


Effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2024.

As trustee, Anthony Hsieh has voting and investment power over the assets of the JLSSAA Trust.

/s/ Greg Smith, as Attorney-in-Fact for Anthony Li Hsieh


Includes 2,555 shares purchased pursuant to the Palomar Holdings, Inc. 2019 Employee Stock Purchase Plan (ESPP).

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.50 to $125.38 (weighted average of $125.1276), inclusive; $125.55 to $126.43 (weighted average of $126.0920), inclusive; $126.55 to $127.47 (weighted average of $126.9549), The Reporting Person undertakes to provide to Palomar Holdings, Inc., any security holder of Palomar Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.


The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.44 to $17.53, inclusive. The reporting person undertakes to provide Antero Midstream Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).

Includes 106,489 shares of Common Stock subject to previously granted RSUs that remain subject to vesting.

Senior Vice President - Accounting and Chief Accounting Officer

/s/ Yvette K. Schultz, as attorney-in-fact for Sheri Pearce


Class A Common Stock

Class A Common Stock

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.05 to $86.46, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Each LLC Unit, together with a share of Class B Common Stock, may be converted by the holder into one share of Class A Common Stock at any time. The LLC Units do not expire.

/s/ John O'Connor, as Attorney-in-Fact for Adrienne Kebodeaux


The sales reported on this line item were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 19, 2025.

The reported price in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.215 to $1.28 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote on this Form 4.

/s/ Tyler Gee, Attorney-in-Fact for Brian McGee


Sale is pursuant to a 10b5-1 Preset Diversification Program dated March 12, 2024 under which Mr. Wessel plans to sell up to 120,000 shares of FirstCash Holdings, Inc. common stock subject to certain minimum price thresholds.

Bona fide gift to a charitable organization.


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

This transaction was executed in multiple trades during the day at prices ranging from $164.43 to $165.36. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Shares are held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust.

This transaction was executed in multiple trades during the day at prices ranging from $167.69 to $168.32. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $165.48 to $166.47. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

This transaction was executed in multiple trades during the day at prices ranging from $166.50 to $167.46. The weighted-average price is reported above. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

/s/ Veena Bhatia, Attorney-in-Fact for Cannon-Brookes Michael


This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 12, 2025.

Shares are held by Farquhar Investment Partnership No. 2.

/s/ Veena Bhatia, Attorney-in-Fact for Farquhar Scott


The reported shares were withheld by the Issuer upon vesting of RSUs to satisfy tax withholding obligations.

A portion of these securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.


The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan established by the Reporting Person on May 2, 2025.

The total securities beneficially owned includes shares of unvested restricted stock units. It excludes unvested performance-based restricted stock units which will be reported when earned upon achievement of certain
performance criteria.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.05, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

These securities of the Company are beneficially owned by (i) Cyrus Capital Partners, L.P. ("Cyrus Capital Partners"), as a result of being the investment manager of certain private investment funds that directly hold the securities, including Cyrus 1740 Master Fund, L.P., Canary SC Master Fund, L.P., Cyrus Opportunities Master Fund II, Ltd., Crescent 1, L.P., CRS Master Fund, L.P., Cyrus Select Opportunities Master Fund, Ltd., Cyrus Select Opportunities Master Fund II, L.P., Peterson Capital Investors LLC, and PJ A Capital LLC (the "Cyrus Funds"), (ii) Cyrus Capital Partners GP, L.L.C. ("Cyrus Capital GP"), as a result of being the sole general partner of Cyrus Capital Partners, and (iii) Stephen C. Freidheim, as a result of being the Chief Investment Officer of Cyrus Capital Partners and the sole member and manager of Cyrus Capital GP (collectively, the "Reporting Persons").

(Continued from footnote 2) Each of the Reporting Persons disclaims beneficial ownership of any securities reported by any person except to the extent of his or its pecuniary interest therein, if any.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.25 to $13.255, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.


Award of service-based restricted stock units, which will vest on August 20, 2026.


Natural Grocers by Vitamin Cottage, Inc.


Common Stock

These restricted stock units vest in four equal annual installments beginning on August 20, 2025 and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.

Represents shares withheld to pay taxes applicable to vesting of restricted stock units.


Common Stock

These restricted stock units vest in four equal annual installments beginning on August 20, 2025, and upon vesting, will each be settled by delivery of one share of common stock, an equivalent amount of cash, or a combination thereof.

Title: Senior Vice President, PST Segment, Demand Generation and Execution


Common Stock

Title: Senior Vice President, Chief Human Resources Officer


Common Stock

Title: Senior Vice President, Corporate Development


Agiri Oluwagbemileke Yusuf

C/O GEVO, INC. 345 INVERNESS DRIVE SOUTH

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.625 to $1.635 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Exhibit 24: Power of attorney provided herewith.


The reported sales were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.570 to $1.605 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Between July 21, 2025 and August 20, 2025, the reporting person disposed of 3.77 shares of the issuer's common stock under the issuer's 401(k) plan to cover administrative fees. The information in this report is based on a plan statement dated July 25, 2025.


The price shown is the weighted average price at which shares were sold in multiple sales transactions made pursuant to a single market order. The range of prices for the transactions made was $129.51 to $129.685. Upon request by SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

Reporting Person is one of three family members who share equal control over the general partner of this limited partnership. Reporting Person disclaims beneficial ownership in the number of shares held by the limited partnership to the extent that she does not have a pecuniary interest.

Reporting Person may be considered part of a "group" with certain family members holding issuer shares; however, Reporting Person disclaims existence of such a "group" and disclaims beneficial ownership of any shares not reported herein.

The price shown is the weighted average price at which shares were sold in multiple sales transactions made pursuant to a single market order. The range of prices for the transactions made was $127.33 to $127.36. Upon request by SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2025.

/s/ Alphonse Valbrune, as Attorney-in-Fact for Souvik Das


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2024.

Includes restricted stock units subject to vesting requirements.


Class A Common Stock

This disposition represents shares withheld to cover tax withholding obligations in connection with the exercise and settlement of stock options. The disposition is mandated by the Issuer and does not represent a discretionary transaction by the Reporting Person.

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2024.

This transaction was executed in multiple trades at prices ranging from $20.00 USD to $20.015 USD; the price reported above reflects the weighted average sale price.

Vests 370,000 share(s) on 19-Mar-2019, 370,000 share(s) on 19-Mar-2020, 610,500 share(s) on 02-Nov-2020, 166,500 share(s) on 19-Mar-2021, 166,500 share(s) on 19-Mar-2022, 166,500 share(s) on 19-Mar-2023

/s/ Alphonse Valbrune, as Attorney-in-Fact, for Sandeep Sahai


Benjamin and Divya Silbermann Family Trust

Class A Common Stock

Class A Common Stock

Class A Common Stock

Represents the conversion of shares of Class B Common Stock, par value $0.00001 ("Class B Common Stock") into Class A Common Stock, par value $0.00001 ("Class A Common Stock"), in connection with the sale of such shares pursuant to a Rule 10b5-1 trading plan.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2024.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.7050 to $35.1900 per share. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Mr. Silbermann disclaims beneficial ownership of the shares held by the SFTC, LLC, a Delaware limited liability company owned by The Silbermann 2012 Irrevocable Trust. This report shall not be deemed an admission that he is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in such shares by virtue of certain of his immediate family members' interests in The Silbermann 2012 Irrevocable Trust.

Represents previously reported RSUs that are subject to vesting requirements.

Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of the Class A Common Stock. Additionally, each share of Class B Common Stock will, subject to certain exceptions, convert automatically into one share of Class A Common Stock upon any transfer,  and in other circumstances as outlined in the Issuer's Certificate of Incorporation.


By irrevocable trust for the benefit of children

This transaction involved the reporting person's spouse transferring shares of EHC common stock to a trust in which the reporting person is a beneficiary.

The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

/S/ Stephen Leasure, attorney-in-fact for Douglas Coltharp


Common Stock

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon settlement.

The RSUs will vest in substantially equal increments on each of September 30, 2025, December 31, 2025, March 31, 2026, and the earlier of (i) June 30, 2026 and (ii) the date immediately preceding the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's provision of services to the Issuer on each vesting date. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting.

RSUs do not expire; they either vest or are canceled prior to vest date


Common Stock

There will be no expiration date once restricted stock units vest.

These restricted stock units vest in four equal annual installments beginning one year after the 08/19/2024 date of grant.

The Form 4 has been updated to clarify that grants of RSUs will be settled in Common Stock.

Shares issued for vesting of 8/19/2024 RSU grant and shares disposed in settlement of tax withholding obligations for such RSU vesting.


Common Stock

Each RSU represents a contingent right to receive one share of Impinj common stock.

One-fourth of the shares subject to the grant shall vest on August 20, 2026, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date.

/s/ Yukio Morikubo, Attorney in fact for Cary Baker


This transaction was executed in multiple trades at prices ranging from $4.865 to $4.890. The price reported above reflects the weighted average purchase price. The reporting person hereby
undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

No Class A Common Stock (UAA) is beneficially owned.

/s/ Mehri F. Shadman, Attorney-in-Fact for Robert John Sweeney


The price reported in Column 4 is a weighted average price. The shares were purchased in more than one transaction at prices ranging from $6.20 to $6.50, inclusive. The Reporting Person(s) undertake(s) to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Represents the total number of shares held after the Issuer's completion of a 1-for-10 reverse stock split that occurred on June 11, 2025.

The price reported in Column 4 is a weighted average price. The shares were purchased in more than one transaction at prices ranging from $6.13 to $6.50, inclusive. The Reporting Person(s) undertake(s) to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. The shares were purchased in more than one transaction at prices ranging from $6.50 to $6.92, inclusive. The Reporting Person(s) undertake(s) to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

/s/ Brittany Gale, Senior Trust Officer of Jackson Hole Trust Company, Trustee


Class B Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date.

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.90 to $185.80, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (12) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.08 to $187.00, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $187.09 to $188.08, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.09 to $189.07, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.09 to $190.08, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.10 to $191.08, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.10 to $192.09, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.10 to $193.08, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.12 to $193.88, inclusive.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.43 to $195.34, inclusive.

Shares subject to the option are fully vested and immediately exercisable.

The shares are held of record by Center Court Partners Ltd., for which the reporting person serves as a partner.

The shares are held of record by Center Court 2020 Trust 1 UA 12/11/20, for which the reporting person serves as trustee.

The shares are held of record by Center Court 2020 Trust 2 UA 12/11/20, for which the reporting person serves as trustee.

The shares are held of record by Center Court 2020 Trust 3 UA 12/11/20, for which the reporting person serves as trustee.

/s/ Lindsey Cochran, by power of attorney


Common Stock

Each RSU represents a contingent right to receive one share of Impinj common stock.

One-fourth of the shares subject to the grant shall vest on August 20, 2026, and 1/16th of the shares subject to the grant shall vest each quarter thereafter, subject to the reporting person's continued service to the Issuer through such date.

/s/ Yukio Morikubo, Attorney in fact for Chris Diorio


These sales were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.00 to $400.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnote below.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.00 to $401.01, inclusive.


Restricted stock units awarded to the reporting person pursuant to the 2021 Intrusion, Inc Omnibus Incentive Plan as part of the Compensation Plan for non-employee directors. Restricted stock units fully vest on the anniversary of the award date.


The tax obligation resulting from the restricted stock units released on August 15, 2025 was covered by shares sold on August 19, 2025.